Poulton Jeffrey V.

EVP, Chief Financial Officer | Chief Financial Officer

1 company

Weak

Trades Analyzed

12M Win Rate

11.1%

Avg 3M Return

-2.2%

Avg 12M Return

-38.3%

Poulton Jeffrey V. is an EVP, Chief Financial Officer at ALNYLAM PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 93 sells.

Estimated insider holdings value: $17.5M based on current market prices.

Holdings by Company

ALNYJan 12, 2026

Current Shares60.0K

Value$17.49M

Net Activity-21,207

Bought: 0Sold: 21.2K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 12, 2026	ALNY Alnylam Pharmaceuticals, Inc.	EVP, Chief Financial Officer	Sell	2,780	$362.87	$1,008,765.87	-0.2%	-13.2%	-
Oct 2, 2025	ALNY Alnylam Pharmaceuticals, Inc.	EVP, Chief Financial Officer	Sell	3,821	$452.05	$1,727,283.60	-0.6%	-13.7%	-
Aug 18, 2025	ALNY Alnylam Pharmaceuticals, Inc.	EVP, Chief Financial Officer	Sell	2,274	$453.27	$1,030,727.12	-0.6%	+0.8%	-
Mar 3, 2025	ALNY Alnylam Pharmaceuticals, Inc.	EVP, Chief Financial Officer	Sell	1,264	$243.78	$308,140.61	-0.4%	+25.7%	+30.9%
Feb 28, 2025	ALNY Alnylam Pharmaceuticals, Inc.	EVP, Chief Financial Officer	Sale+OE	882	$242.01	$213,449.52	-0.3%	+18.7%	+34.9%
Feb 14, 2025	ALNY Alnylam Pharmaceuticals, Inc.	EVP, Chief Financial Officer	Sell	967	$255.17	$246,749.79	-0.2%	+10.5%	+22.6%
Nov 26, 2024	ALNY Alnylam Pharmaceuticals, Inc.	EVP, Chief Financial Officer	Sell	1,682	$250.98	$422,144.31	-1.1%	-1.7%	+75.7%
Jun 25, 2024	ALNY Alnylam Pharmaceuticals, Inc.	EVP, Chief Financial Officer	Sell	1,605	$231.00	$370,747.09	-0.4%	+13.2%	+34.1%
Feb 28, 2024	ALNY Alnylam Pharmaceuticals, Inc.	EVP, Chief Financial Officer	Sale+OE	574	$155.30	$89,144.57	-0.6%	-3.3%	+52.7%
Feb 16, 2024	ALNY Alnylam Pharmaceuticals, Inc.	EVP, Chief Financial Officer	Sell	1,007	$148.06	$149,099.42	-1.8%	+2.9%	+74.5%